Burosumab
Last Updated: 06/30/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 341 publications
Hypophosphatemic rickets: diagnosis and treatment.
Journal: Archives of endocrinology and metabolism
Published: May 15, 2026
Burosumab treatment for children younger than 12 months with X-linked hypophosphataemia.
Journal: The lancet. Diabetes & endocrinology
Published: March 18, 2026
Burosumab an emerging therapy in TIO: a local clinical survey and a systematic review with individual patient data analysis.
Journal: Frontiers in endocrinology
Published: February 04, 2026
Endocrine-related osteoporosis: the state of the art.
Journal: Frontiers in endocrinology
Published: January 27, 2026
Metabolic bone diseases : what's new in 2025
Journal: Revue medicale suisse
Published: January 22, 2026
Second interim analysis of the post-authorisation safety study (PASS) of burosumab in paediatric patients with X-linked hypophosphataemia.
Journal: European journal of endocrinology
Published: January 20, 2026
A phase 2 trial of burosumab for treatment of fibroblast growth factor-23 mediated hypophosphatemia in children and adults with fibrous dysplasia.
Journal: medRxiv : the preprint server for health sciences
Published: January 02, 2026
Treatment of Fibroblast Growth Factor-23-Mediated Renal Phosphate Wasting With Burosumab in a Patient With Chronic Kidney Disease 3b: A Case Report.
Journal: Cureus
Published: December 22, 2025
XLH Matters 2024 GCC Edition: Insights and Recommendations to Improve Outcomes for People Living With XLH in the Gulf Region.
Journal: Clinical medicine insights. Endocrinology and diabetes
Published: December 19, 2025
Expanding the Autosomal Recessive Hypophosphatemic Rickets Type I Carrier Phenotype and Adult Treatment with Burosumab.
Journal: Calcified tissue international
Published: December 04, 2025
Last Updated: 06/30/2026